“Ataxia-Telangiectasia Mutated (ATM) inhibitor induces antineoplastic effects in brain cancer cells: Evidence from in vitro investigations”, CRM, vol. 3, no. 1, pp. 29–38, Jun. 2026, doi: 10.63626/21zenk44.